Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study

Mick Serpell, Shiva Tripathi, Sabine Scherzinger, Sònia Rojas-Farreras, Alexander Oksche and Margaret Wilson ()

The Patient: Patient-Centered Outcomes Research, 2016, vol. 9, issue 1, 35-46

Abstract: In everyday clinical practice, TDB was well tolerated and patients were satisfied with their therapy. Self-reported adherence to TDB was very high, and adverse events rarely resulted in treatment discontinuation. Opportunities were identified to limit common adverse events associated with TDB. Copyright The Author(s) 2016

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1007/s40271-015-0151-y (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:patien:v:9:y:2016:i:1:p:35-46

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40271

DOI: 10.1007/s40271-015-0151-y

Access Statistics for this article

The Patient: Patient-Centered Outcomes Research is currently edited by Christopher I. Carswell

More articles in The Patient: Patient-Centered Outcomes Research from Springer, International Academy of Health Preference Research
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().